Publication:
Giant cell arteritis: is the clinical spectrum of the disease changing?

dc.contributor.authorGonzález-Gay, Miguel Á.
dc.contributor.authorOrtego-Jurado, Miguel
dc.contributor.authorErcole, Liliana
dc.contributor.authorOrtego-Centeno, Norberto
dc.contributor.authoraffiliation[González-Gay,MÁ] Division of Rheumatology and Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, Instituto de Investigación Marqués de Valdecilla, Santander, Spain. [González-Gay,MÁ] University of Cantabria, Santander, Spain. [González-Gay,MÁ] Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. [Ortego-Jurado,M] Emergency Health Services Agency-061 (EPES-061), Granada, Spain. [Ercole,L] Medical Department, Roche Pharma, Madrid, Spain. [Ortego-Centeno,N] Autoimmune Diseases Unit, Hospital Universitario San Cecilio, Instituto de Investigación Biosanitaria de Granada (IBS. GRANADA), Department of Internal Medicine, Professor of Medicine of the University of Granada, Granada, Spain.
dc.contributor.funderThis review was funded by Roche Farma S.A. Spain.
dc.date.accessioned2020-08-19T12:27:31Z
dc.date.available2020-08-19T12:27:31Z
dc.date.issued2019-07-29
dc.description.abstractBackground: Giant cell arteritis is a vasculitis of large and middle-sized arteries that affects patients aged over 50 years. It can show a typical clinical picture consisting of cranial manifestations but sometimes nonspecific symptoms and large-vessel involvement prevail. Prompt diagnosis and treatment is essential to avoid irreversible damage. Discussion: There has been an increasing knowledge on the occurrence of the disease without the typical cranial symptoms and its close relationship and overlap with polymyalgia rheumatica, and this may contribute to reduce the number of underdiagnosed patients. Although temporal artery biopsy is still the gold-standard and temporal artery ultrasonography is being widely used, newer imaging techniques (FDG-PET/TAC, MRI, CT) can be of valuable help to identify giant cell arteritis, in particular in those cases with a predominance of extracranial large-vessel manifestations. Conclusions: Giant cell arteritis is a more heterogeneous condition than previously thought. Awareness of all the potential clinical manifestations and judicious use of diagnostic tests may be an aid to avoid delayed detection and consequently ominous complications.es_ES
dc.description.versionYeses_ES
dc.identifier.citationGonzález-Gay MÁ, Ortego-Jurado M, Ercole L, Ortego-Centeno N. Giant cell arteritis: is the clinical spectrum of the disease changing? BMC Geriatr. 2019 Jul 29;19(1):200.es_ES
dc.identifier.doi10.1186/s12877-019-1225-9es_ES
dc.identifier.essn1471-2318
dc.identifier.pmcPMC6664782
dc.identifier.pmid31357946es_ES
dc.identifier.urihttp://hdl.handle.net/10668/3158
dc.journal.titleBMC Geriatrics
dc.language.isoen
dc.page.number7 p.
dc.publisherBioMed Central Ltd.es_ES
dc.relation.publisherversionhttps://bmcgeriatr.biomedcentral.com/articles/10.1186/s12877-019-1225-9es_ES
dc.rights.accessRightsopen access
dc.subjectGiant-cell arteritises_ES
dc.subjectPolymyalgia rheumatices_ES
dc.subjectFDG-PET/CTes_ES
dc.subjectArteritis de células giganteses_ES
dc.subjectPolimialgia reumáticaes_ES
dc.subjectFluorodeoxyglucose F18es_ES
dc.subjectFluorodesoxiglucosa F18es_ES
dc.subjectPositron Emission Tomography Computed Tomographyes_ES
dc.subjectTomografía Computarizada por Tomografía de Emisión de Positroneses_ES
dc.subject.meshMedical Subject Headings::Persons::Persons::Age Groups::Adult::Agedes_ES
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures, Operative::Biopsyes_ES
dc.subject.meshMedical Subject Headings::Check Tags::Femalees_ES
dc.subject.meshMedical Subject Headings::Diseases::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Vasculitis, Central Nervous System::Giant Cell Arteritises_ES
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humanses_ES
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures, Operative::Surgical Procedures, Minimally Invasive::Magnetic Resonance Imaging, Interventionales_ES
dc.subject.meshMedical Subject Headings::Check Tags::Malees_ES
dc.subject.meshMedical Subject Headings::Persons::Persons::Age Groups::Adult::Middle Agedes_ES
dc.subject.meshMedical Subject Headings::Diseases::Musculoskeletal Diseases::Rheumatic Diseases::Polymyalgia Rheumaticaes_ES
dc.subject.meshPositron Emission Tomography Computed Tomographyes_ES
dc.subject.meshMedical Subject Headings::Anatomy::Cardiovascular System::Blood Vessels::Arteries::Cerebral Arteries::Temporal Arterieses_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Carbohydrates::Deoxy Sugars::Deoxyglucose::Fluorodeoxyglucose F18es_ES
dc.titleGiant cell arteritis: is the clinical spectrum of the disease changing?es_ES
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
GonzalezGay_GiantCell.pdf
Size:
591.53 KB
Format:
Adobe Portable Document Format
Description:
Material editorial